
Supriya Lifescience Ltd Surges 7.35% to Day's High of Rs 734.2 — Outperforms Sector by 6.65 Percentage Points
2026-05-19 11:01:18The Sensex rose 0.57% on 19 May 2026, yet Supriya Lifescience Ltd outpaced the broader market with a 7.35% gain, touching an intraday high of Rs 734.2. This 6.65 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector signals a distinctly stock-specific rally rather than a market-wide lift.
Read MoreSupriya Lifescience Gains 2.25%: Technical Shift and Hold Upgrade Highlight Week
2026-05-09 11:04:13Key Events This Week May 4: Week opens at Rs.692.20 May 6: Stock rallies 1.46% amid strong Sensex gains May 7: Slight dip of 0.43% as technical signals remain mixed May 8: MarketsMOJO upgrades rating to Hold; stock closes at Rs.707.80 (+1.06%) Week OpenRs.692.20 Week CloseRs.707.80<div cl...
Read More
Supriya Lifescience Ltd is Rated Sell
2026-05-07 10:11:23Supriya Lifescience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Supriya Lifescience Ltd Surges 7.7% to Day's High of Rs 697.4 — Outperforms Sector by 5.4 Percentage Points
2026-04-27 09:46:10The Sensex advanced 0.6% on 27 Apr 2026, yet Supriya Lifescience Ltd outpaced the broader market with a 7.71% gain, touching an intraday high of Rs 697.4. This 5.43-percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a market-wide lift.
Read More
Supriya Lifescience Ltd is Rated Sell
2026-04-26 10:10:34Supriya Lifescience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Supriya Lifescience Ltd is Rated Sell
2026-04-15 10:10:52Supriya Lifescience Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 27 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-04-13 08:04:25Supriya Lifescience Ltd has experienced a subtle shift in its technical momentum, moving from a bearish to a mildly bearish trend, reflecting a complex interplay of technical indicators. Despite a modest daily price increase of 1.22%, the stock’s broader technical signals suggest cautious investor sentiment amid mixed momentum cues.
Read MoreSupriya Lifescience Gains 3.50% This Week: Key Technical Shifts and Volatility Insights
2026-04-11 11:02:35Key Events This Week 6 Apr: Week opens at Rs.616.40 7 Apr: Stock dips 1.23% despite Sensex rising 0.50% 8 Apr: Strong gap up opening with 9.21% surge, intraday high Rs.664.85 9 Apr: Price retreats 1.10% amid mixed market signals 10 Apr: Week closes at Rs.637.95, up 1.43% on the day Week OpenRs.616.40 <di...
Read More
Supriya Lifescience Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals
2026-04-08 08:03:57Supriya Lifescience Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its technical outlook deteriorate from mildly bearish to bearish, reflecting a shift in price momentum and mixed signals from key technical indicators. Despite a modest weekly price gain, the stock’s overall trend and momentum indicators suggest caution for investors amid a challenging market environment.
Read MoreAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15-Jun-2026 | Source : BSEIntimation of Analyst / Investor Meeting is enclosed herewith.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
09-Jun-2026 | Source : BSEIntimation of Investor/Analyst call is enclosed.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
02-Jun-2026 | Source : BSEEarnings Call Transcript is enclosed herewith.
Corporate Actions
No Upcoming Board Meetings
Supriya Lifescience Ltd has declared 50% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available